Carbon Biosciences
Focus: Carbon Biosciences is a publicly traded biotech company headquartered in Waltham, MA, specializing in gene therapy. The company maintains a portfolio spanning anesthetics, contrast agents, and wound care, with early-stage oncology and urology programs in development.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Carbon Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Carbon Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Carbon Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak
Established diagnostic agent at peak revenue lifecycle; core revenue base supporting R&D operations.
Help build intelligence for Carbon Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.